key: cord-0901107-a3hhrndr
authors: Di Mauro, Marco; Migliaccio, Marco Giuseppe; Ricciolino, Riccardo; Spiniello, Giorgio; Carfora, Vincenzo; Verde, Nicoletta; Mottola, Filiberto Fausto; Coppola, Nicola
title: Acute kidney injury in COVID-19: a case-report
date: 2020-09-08
journal: Int Urol Nephrol
DOI: 10.1007/s11255-020-02635-3
sha: 0b5fd5d2f5d04b79f13c60ef1f5ebd76972c0ecb
doc_id: 901107
cord_uid: a3hhrndr

nan

(SCr) of 2.7 mg/dL, 3 days after the angio-CT scan (day 7 from hospitalization, Table 1 ).

So, a contrast induced nephropathy (CIN) was suspected, and intravenous hydration therapy started. The patient did not drink any water, and also presented clinical signs of dehydration. Urinalysis was normal. She showed a restoration of a normal diuresis and improvement of renal function (SCr and GFR), although never as normal as before the admission. She also developed unexplained anemia and thrombocytopenia, initially interpreted as related to enoxaparine, but more probably related to COVID-19.

After 30 days of hospitalization, and two swab test resulted negative for SARS-CoV2, the patient was discharged in a good respiratory and clinical condition.

Analyzing the possible causes of acute kidney injury (AKI), we can reasonably consider it as a CIN, for the onset of the renal function impairment occurred 3 days after intravenous contrast administration [1] . Rheumatoid arthritis (RA) or other causes of renal damage, as glomerulonephritis, seem to be unlikely, respectively due to the good control of RA and to the absence of worsening hypertension, proteinuria or hematuria caused by an acute glomerulonephritis.

The progression of renal damage cannot be attributed to the radiocontrast agent only: in fact, despite the restoration of a normal diuresis and the improvement of kidney function, SCr and GFR never returned to pre-hospitalization values, as we could usually expect in a CIN treated properly, and without a previous history of chronic kidney disease [2] .

Furthermore, marked hypotension and the simultaneous deterioration of respiratory function suggested COVID-19 infection may have played a role [3, 4] . Increasing of LDH, D-Dimer and thrombocytopenia suggests a high inflammatory response to the infection. We can suppose that inflammation and immune response played an important role in the development of AKI, along with CIN [5] [6] [7] .

The present clinical case suggests that during COVID-19 AKI may occur because of different causes that the physician should identify for a good management. 

Contrast-induced nephropathy

The prevention and management of contrast-induced acute kidney injury: a mini-review of the literature

Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection

Renal involvement and early prognosis in patients with COVID-19 Pneumonia

Cytokine storm and sepsis disease pathogenesis

Lung-kidney crosstalk in the critically ill patient

Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations